Margaret is a Non-Executive Director on the Board of Wintermute Biomedical Group, is Co-Chair of RACI’s Inclusion and Diversity Committee and runs Hartley Advisory. A member of ATSE’s Victorian Division Committee she co-ordinates parliamentary briefings. She has board experience, in NFP sector (e.g., Chair ACOLA Secretariat Ltd, Crawford Fund Pty Ltd) and was CEO of ATSE (2009 – 2019) leading the delivery of strategic policy research for technology solutions to major challenges facing Australia. Prior, she held leadership roles with the Australian Government (e.g., Australia’s Chemicals Regulator, founder and Director Office of Chemical Safety and Principal Science Adviser Department of Health.

Dr. Margaret Hartley's career has shown exemplary contributions and leadership of activities overseeing the regulation of chemicals in Australia. Under her directorship the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) instigated a regulatory scheme that was both pragmatic from an industry point of view while protecting the interests of the community. The reviews she conducted found their way into worksafe and other regulations. The Priority Existing Chemicals were selected from a list of chemicals that had never been assessed previously and are now listed on the Australian Inventory of Chemical Substances (AICS). She is recognised internationally for her work.